Isabella Presch/LinkedIn
Aug 29, 2026, 15:43
Isabella Presch: ASH 2026 ITP Guidelines – Beyond Platelet Counts
Isabella Presch, Senior Medical Director Rare diseases, Advanced therapies and Pediatrics at Fortrea, shared a post on LinkedIn:
”Patients don’t measure success by platelet counts alone, but by the ability to live their lives with confidence.
The updated American Society of Hematology 2026 ITP Guidelines place greater emphasis on reducing steroid burden, improving durable responses, and incorporating patient preferences into treatment decisions.
It’s an important step toward care that focuses not only on disease control, but also on quality of life, daily functioning, and outcomes that matter most to patients.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting
-
Oct 16, 2026, 17:50Elad AsherÖ‰ STORM-PE Shows Functional Benefits of Thrombectomy
-
Oct 16, 2026, 17:32Shruthi Narayan: STORM-PE and STRIKE-PE Studies Advance Understanding of Recovery After Pulmonary Embolism
-
Oct 16, 2026, 17:22Wolfgang MiesbachÖ‰ What a Near-Perfect FISH Score Fails to See
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke
-
Oct 16, 2026, 17:03Only 5 Days Left to Submit Your Research for EAHAD 2027
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand